EGFR and lung adenocarcinoma: Wang et al. [27] also confirmed that FAR2P1 was highly expressed in the EGFR exon 19 deletion group of lung adenocarcinoma and that differential expression of FAR2P1 was associated with the development and progression of non-small cell lung cancer [28].